Chemical | 17 March 2021
Olin reduces chlor alkali production capacity by 50% permanently at Alabama facility
The closure is expected to be completed by March 31, 2021.
The closure is expected to be completed by March 31, 2021.
Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.
The new ‘Pad-Ox G2 Cold’ dyeing process works thanks to the insertion of very small machinery into the existing finishing range process.
Under the agreement, Novozymes will continue to utilize direct sales in addition to Univar Solutions’ strong distribution capability to address customers of all sizes
Borealis filed 179 patent applications in 2019.
Chemical prices continued their recovery course in the fourth quarter.
Olin's first quarter 2021 adjusted EBITDA was expected to be in the $400 to $425 million range.
The “Chemicals Strategy for Sustainability - For a Pollutant-Free Environment” published by the EU Commission brings with it major changes for the chemical industry and the use of chemicals.
Price increase effective from April 15, 2021.
Bota Bio will use this investment to expand its development and production capabilities.
Ashland will build upon our previous investments in Nanjing and further expand capacity.
The agreement concerns Agilyx’s pyrolysis advanced technology to convert mixed waste plastics into high-value circular products and fuels
With the acquisition, MBCC Group will enlarge its portfolio in acrylates and polyurethane.
The acquisition will enhance Sika’s position in the region of Minas Gerais.
Asahi Kasei has been proactively expanding its environmentally friendly LIB separator business
Over 30 top CEOs from India and abroad will be deliberating at the Global CEOs Forum.
The new facilities are designed to increase creativity and improve collaboration with customers.
This increase is necessary due to the increasing costs of doing business in all regions.
The vaccine was 85 percent effective in preventing severe disease across all regions.
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
Subscribe to our newsletter & stay updated.
